Entering text into the input field will update the search result below

Theravance Biopharma Inc. (TBPH) Q4 2022 Earnings Call Transcript

Feb. 27, 2023 9:25 PM ETTheravance Biopharma, Inc. (TBPH)
SA Transcripts profile picture
SA Transcripts

Theravance Biopharma Inc. (NASDAQ:TBPH) Q4 2022 Results Conference Call February 27, 2023 5:00 PM ET

Company Participants

Rick Winningham - Chairman and Chief Executive Officer

Rhonda Farnum - Senior Vice President, Chief Business Officer

Rick Graham - Senior Vice President, Research and Development

Aziz Sawaf - Chief Financial Officer

Conference Call Participants

David Risinger - SVB Securities

Douglas Tsao - H.C. Wainwright

Eva Privitera - Cowen

Vikram Purohit - Morgan Stanley

Liisa Bayko - Evercore ISI


Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma Fourth Quarter and Full Year 2022 Conference Call. [Operator Instructions].

Also, today's conference is being recorded. And now I'd like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead.

Rick Winningham

Good afternoon, and thank you for joining the Theravance Biopharma fourth quarter and full year 2022 conference call to discuss our business. I'll remind you that this call will contain forward-looking statements that involve risks and uncertainties, including statements about our development pipeline, expected benefits of our products, anticipated timing of clinical trials, regular filings and expected financial results.

Information concerning factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC.

I drift your attention to Slide 3. Joining me today are Rhonda Farnum, Chief Business Officer; Rick Graham, Research and Development; and Aziz Sawaf, Chief Financial Officer. Before I get started, I'd like to make a brief statement regarding public announcement that provide made earlier today, the Board management are committed to acting in the best interest of the company and all of its shareholders, and we're open to evaluating all ideas to maximize shareholder value, including those from Irenic.

We're disappointed that Irenic has chosen to make a public announcement

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About TBPH

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TBPH

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.